IFAN executive committee

Paediatric Allergists: Dr. Aideen Byrne, Dr. John Fitzsimons, Professor Jonathan O’B Hourihane

General Practice: Dr. Fiona Magee

Non Consultant Hospital Doctors:  Dr. Miranda Crealey, (Higher Specialist Trainee, Paediatrics) & Dr. Carol Stephens (Basic Specialist Trainee, Paediatrics)

Parent: Niamh Flynn

Registered Dietitian: Ruth Charles (Secretary)


IFAN core working group

Dr. Aideen Byrne Tertiary Consultant in Paediatric Allergy
Ruth Charles Paediatric Dietitian, Irish Nutrition & Dietetic Institute
Deirdre Daly Clinical Nurse Specialist in Allergy
Dr. John Fitzsimons Secondary Care Consultant in Paediatrics
Professor Jonathan O’B Hourihane Tertiary Care Consultant Paediatric Allergy
Dearbhla Hunt Paediatric Dietitian, Irish Nutrition & Dietetic Institute
Teresa Kelly Paediatric Dietitian, Irish Nutrition & Dietetic Institute
Dr. Imelda Lambert Secondary Care Consultant Paediatrics
Dr. Teresa Mc Sweeney Senior Area Medical Officer, HSE
Dr. Sean O’ Callaghan Primary Care, ICGP
Caroline O’Connor Community Dietitian, Irish Nutrition & Dietetic Institute



IFAN’s work in producing these documents has been made possible by sponsorship from (alphabetical):

CMA3danone mead-johnson SMA-logo3thermofisher

Disclosure statements from Danone Baby Nutrition, Mead Johnson Nutrition, Nutricia Advanced Medical Nutrition, Thermofisher Scientific, SMA Nestle

Special thanks to Bronagh Clarke, Emily Butler and all the staff at UCC’s Department of Paediatrics & Child Health for their highly efficient administration.

Thanks to Dr. James McIntosh and staff at Safefood for facilitating network meetings.

Thanks to all IFAN members and Anaphylaxis Ireland for their ongoing contributions and support.


This guidance represents the view of IFAN, which was arrived at after careful consideration of the evidence available for example, UK’s National Health Service’s National Institute for Health and Clinical Excellence (NICE), British Society for Allergy and Clinical Immunology (BSACI), World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA), among others, where grading of recommendations assessment, development and evaluation (GRADE) was used as a method to assess study quality. However, where GRADE was not appropriate, quality assessments were based on critical appraisal of the study design and limitations. GRADE is currently only developed for intervention studies .and not appropriate for clinical questions.  Where GRADE was not used, its principles (indirectness, limitations, inconsistency, imprecision and other considerations) formed part of the discussion of the evidence with the core working group.  Healthcare professionals are expected to take it fully into account when exercising their clinical judgment.  However, the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian, and informed by the summary of product characteristics of any drugs they are considering.